Dr. Robert Dave Feinstein, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 400 Fairview Heights Rd, Suite 202, Summersville, WV 26651 Phone: 304-872-8411 Fax: 304-872-0442 |
News Archive
Bruker Corporation today announced the closing of its acquisition of Center for Tribology, Inc. (CETR) for $13 million in cash as an initial purchase price, with potential additional earn-out payments of up to $4 million in cash, depending on growth and profitability of the CETR-business within Bruker in 2012 and 2013.
A USAID official said Tuesday that potential violence following the release of Haiti's final presidential election results could interfere with efforts to contain the country's cholera epidemic, CBC News reports. "What we all worry about is if there is violence again and it disrupts for a couple of days," said Mark Ward, acting director of USAID's Office of U.S. Foreign Disaster Assistance. "That's my biggest headache right now," he added.
Scientists at St. Boniface Hospital Albrechtsen Research Centre and the University of Manitoba have developed a drug that combats 2 of the top 10 "priority pathogens" recently defined by the World Health Organization as antiobiotic-resistant bacteria requiring new interventions.
Surgeons at the University of California, San Diego, School of Medicine and University of Washington Medical Center have determined that transorbital neuroendoscopic surgery is a safe and effective option for treating a variety of advanced brain diseases and traumatic injuries. This groundbreaking minimally invasive surgery is performed through the eye socket, thus eliminating the removal of the top of the skull to access the brain.
BIOTRONIK SE & Co KG, the pioneer in wireless remote monitoring technology for patients with cardiac devices, today announced the tenth anniversary of BIOTRONIK Home Monitoring®—the world's first wireless, mobile patient monitoring technology—to be celebrated during Cardiostim in Nice, France.
› Verified 6 days ago